Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.75M | -56.76M | 44.78M | 35.60M | 32.74M |
| Total Depreciation and Amortization | -- | 45.06M | -22.42M | 22.16M | -- |
| Total Amortization of Deferred Charges | -- | 5.55M | -2.78M | 2.75M | -- |
| Total Other Non-Cash Items | 4.46M | 106.49M | -57.89M | 37.38M | -12.66M |
| Change in Net Operating Assets | -- | -28.30M | 94.39M | -93.31M | -- |
| Cash from Operations | 27.21M | 72.04M | 56.08M | 4.57M | 20.09M |
| Capital Expenditure | -6.61M | -10.91M | -10.59M | -12.53M | -15.54M |
| Sale of Property, Plant, and Equipment | 4.80K | 298.50K | 8.30K | -15.60K | 33.70K |
| Cash Acquisitions | -310.50K | -47.50M | -3.45M | 512.70K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.53M | 194.90M | -139.81M | -609.67M | -1.17M |
| Cash from Investing | -90.45M | 136.79M | -153.84M | -621.70M | -16.68M |
| Total Debt Issued | 555.36M | 535.94M | 1.33B | 1.14B | 373.01M |
| Total Debt Repaid | -319.01M | -2.00B | -1.23B | -723.24M | -82.90M |
| Issuance of Common Stock | 62.60M | 71.22M | 285.26M | 33.20M | 21.30M |
| Repurchase of Common Stock | -- | -270.89M | -- | -277.86M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.72M | -4.63M | -76.09M | -4.68M | -4.22M |
| Other Financing Activities | -375.75M | 263.66M | -317.71M | 63.27M | -278.72M |
| Cash from Financing | -14.28M | -198.85M | -66.80M | 28.14M | 337.70K |
| Foreign Exchange rate Adjustments | 681.80K | 2.06M | -3.24M | 904.20K | -706.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.83M | 12.04M | -167.80M | -588.08M | 3.04M |